METROPOLIS vs SURAKSHA: Stock Comparison
METROPOLIS HEALTHCARE is the larger company by market capitalisation. METROPOLIS HEALTHCARE shows lower leverage and a higher net margin, while SURAKSHA DIAGNOSTIC shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
METROPOLIS leads 6; SURAKSHA leads 7 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | METROPOLIS | SURAKSHA |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Service Provider | Healthcare Service Provider |
Price
| Metric | METROPOLIS | SURAKSHA |
|---|---|---|
| Live Price | ₹564.2 | ₹341.7 |
| Day Change | -0.18% | 0.21% |
| Volume | 1.96 L | 1.26 L |
| 52-Week High | ₹2,060 | ₹384 |
| 52-Week Low | ₹412.25 | ₹224.1 |
| Distance from 52W High | -72.61% | -11.02% |
Valuation
| Metric | METROPOLIS | SURAKSHA |
|---|---|---|
| Market Cap | ₹11,717 Cr | ₹1,801 Cr |
| P/E Ratio | 52.2x | 43.06x |
| P/B Ratio | 7.13x | 6.52x |
| EPS | ₹3.63 | ₹2.5 |
| Book Value | ₹73.49 | ₹46.75 |
| Dividend Yield | 0.18% | 0.29% |
Growth
| Metric | METROPOLIS | SURAKSHA |
|---|---|---|
| Revenue Growth (TTM YoY) | 23% | 31.2% |
| EPS Growth (TTM YoY) | 73% | -5.4% |
| Qtr Sales Growth | 10.35% | 0% |
| Qtr Profit Growth | 32.7% | 0% |
Profitability & Leverage
| Metric | METROPOLIS | SURAKSHA |
|---|---|---|
| ROE | 11.31% | 13.64% |
| ROCE | 12.52% | 15.19% |
| Net Margin | 11.55% | 10.37% |
| Operating Margin | 16.88% | 19.81% |
| Debt to Equity | 0x | 0.01x |
Shareholding
As of Sep 2026 • change vs previous quarter| Metric | METROPOLIS | SURAKSHA |
|---|---|---|
| Promoter Holding | 47.82%▼ 1.04 pp | 49.1% |
| FII Holding | 11.67%▲ 0.64 pp | 13.97%▲ 0.5 pp |
| DII Holding | 35.49%▲ 0.37 pp | 21.56%▼ 1.67 pp |
| Public Holding | 5.02%▲ 0.03 pp | 15.37%▲ 1.16 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: METROPOLIS HEALTHCARE and SURAKSHA DIAGNOSTIC.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.

